Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Tyler Blankenship

Physician Assistant Norfolk, VA Physician Assistant

NPI 1679925606 CMS profile 10579184

600 Gresham Dr Ste 8620, Norfolk, VA 23507

Open in the dashboard

General payments

$5,300

69 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Tyler Blankenship of Norfolk, VA is reported in the CMS Open Payments database as having received $5,300 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $562 10
2024 General $2,221 23
2023 General $979 13
2022 General $1,034 18
2021 General $504 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tyler Blankenship
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Tyler Blankenship were reported at $562. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Tyler Blankenship Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $504 $132 $37–$438 $132
2022 $1,034 $155 $48–$522 $149
2023 $979 $167 $52–$557 $160
2024 $2,221 $178 $55–$600 $164
2025 $562 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $2,754 26 payments
  2. Inari Medical, Inc. $485 18 payments
  3. Penumbra, Inc. $435 3 payments
  4. W. L. Gore & Associates, Inc. $291 2 payments
  5. Stryker Corporation $216 6 payments
  6. Philips Electronics North America Corporation $197 2 payments
  7. Baxter Healthcare $166 4 payments
  8. Silk Road Medical, Inc. $125 1 payment
  9. Janssen Pharmaceuticals, Inc $125 1 payment
  10. Boston Scientific Corporation $120 1 payment
  11. Other $386 5 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,300 69 payments
Products named General payments · program years 2021–2025
  1. ENDURANT IIS $2,523 23 payments
  2. FLOWTRIEVER CATHETER, S $485 18 payments
  3. CT THROMBECTOMY SYSTEM KIT $485 18 payments
  4. Indigo System $435 3 payments
  5. Endurant $231 3 payments
  6. LIMFLOW SYSTEM $216 6 payments
  7. PREVELEAK $166 4 payments
  8. GORE DRYSEAL FLEX Introducer Sheath $165 1 payment
  9. GORE EXCLUDER AAA Endoprosthesis $126 1 payment
  10. ENROUTE Transcarotid Neuroprotection System $125 1 payment
  11. Other $1,230 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

134

Median for Physician Assistant: 241

Drug cost

$12,092

Median for Physician Assistant: $4,110

Branded share of claims

70.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Brilinta Ticagrelor Brand 14 $6,090
Eliquis Apixaban Brand 11 $5,384
Clopidogrel Clopidogrel Bisulfate Brand 39 $383
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 31 $114
Atorvastatin Calcium Generic 12 $52
Oxycodone Hcl Generic 16 $48
Carvedilol Generic 11 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$1,868

Medicare's payments for the services billed

Medicare patients

26

Average age 68

Services billed

27

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 75%
Ischemic heart disease 73%
Heart failure 69%
Diabetes 62%
Atrial fibrillation 42%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record